ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,850.16
      -0.54%
      US Tech 100
      20,335.60
      -0.56%
      Dow Jones
      42,291.09
      -0.59%
      Brent Oil
      76.075
      3.01%
      Bitcoin
      97,199.00
      2.98%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Hancock Jaffe Laboratories Inc (HJLI) Quote

      Hancock Jaffe Laboratories Inc

      Hancock Jaffe Laboratories Inc (HJLI)

      NASDAQ
      10.38
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      10.38
      Bid
      10.00
      Ask
      10.70
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      98.319M
      Previous Close
      10.38
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      9,472,000
      Dividend Yield
      -
      PE Ratio
      -4.18
      Earnings Per Share (EPS)
      -2.48
      Revenue
      -
      Net Profit
      -23.52M

      About Hancock Jaffe Laboratories Inc

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.envveno.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      HJLI Latest News

      More News

      Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

      IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

      February 19 2019
      GlobeNewswire Inc.

      Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

      IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

      January 28 2019
      GlobeNewswire Inc.

      Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

      IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

      January 15 2019
      GlobeNewswire Inc.

      Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

      IRVINE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

      January 09 2019
      GlobeNewswire Inc.

      Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

      IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

      December 17 2018
      GlobeNewswire Inc.

      Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

      IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

      December 04 2018
      GlobeNewswire Inc.

      Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

      IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

      November 20 2018
      GlobeNewswire Inc.

      Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

      IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

      November 13 2018
      GlobeNewswire Inc.

      Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute

      IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

      October 09 2018
      GlobeNewswire Inc.

      Hancock Jaffe Appoints Three New Independent Directors

      Accomplished medical device professionals and nationally recognized fund manager and analystbring key experience to the leadership of cardiac and vascular device company IRVINE, Calif., Oct...

      October 02 2018
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      HJLI - Frequently Asked Questions (FAQ)

      What is the current Hancock Jaffe Laboratories share price?
      The current share price of Hancock Jaffe Laboratories is $ 10.38
      How many Hancock Jaffe Laboratories shares are in issue?
      Hancock Jaffe Laboratories has 9,472,000 shares in issue
      What is the market cap of Hancock Jaffe Laboratories?
      The market capitalisation of Hancock Jaffe Laboratories is USD 98.32M
      What is the 1 year trading range for Hancock Jaffe Laboratories share price?
      Hancock Jaffe Laboratories has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Hancock Jaffe Laboratories?
      The price to earnings ratio of Hancock Jaffe Laboratories is -4.18
      What is the reporting currency for Hancock Jaffe Laboratories?
      Hancock Jaffe Laboratories reports financial results in USD
      What is the latest annual profit for Hancock Jaffe Laboratories?
      The latest annual profit of Hancock Jaffe Laboratories is USD -23.52M
      What is the registered address of Hancock Jaffe Laboratories?
      The registered address for Hancock Jaffe Laboratories is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
      What is the Hancock Jaffe Laboratories website address?
      The website address for Hancock Jaffe Laboratories is www.envveno.com
      Which industry sector does Hancock Jaffe Laboratories operate in?
      Hancock Jaffe Laboratories operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ONCBeiGene Ltd
       182.81
      (725.33%)
      		59.37k
      RAINRain Enhancement Technologies Holdco Inc
       5.46
      (351.24%)
      		137.31k
      NITON2OFF Inc
      $ 1.0709
      (331.81%)
      		559.8M
      CTCXCarmell Corporation
      $ 0.757
      (171.23%)
      		296.77M
      BGLCBioNexus Gene Lab Corporation
      $ 0.5946
      (112.58%)
      		179.27M
      NMRANeumora Therapeutics Inc
      $ 1.9781
      (-81.34%)
      		35.32M
      THCHTH International Limited
      $ 0.714296
      (-79.88%)
      		35.3k
      SISIShineco Inc
      $ 2.16
      (-52.32%)
      		1.44M
      SIDUSidus Space Inc
      $ 3.04
      (-37.96%)
      		10.58M
      BDMDBaird Medical Investment Holdings Ltd
      $ 4.77
      (-37.24%)
      		3.36M
      NITON2OFF Inc
      $ 1.075
      (333.47%)
      		559.81M
      CTCXCarmell Corporation
      $ 0.7552
      (170.58%)
      		296.77M
      CGBSCrown LNG Holdings Ltd
      $ 0.6815
      (70.33%)
      		268.84M
      MBIOMustang Bio Inc
      $ 0.2627
      (48.42%)
      		263.86M
      BGLCBioNexus Gene Lab Corporation
      $ 0.5979
      (113.76%)
      		179.33M

      Discussion

      View Full Feed
      mike papa mike papa 3 minutes ago
      Amen.
      XCRT
      MrAce MrAce 3 minutes ago
      Something of interest....KB should engage ALL of the producers in that area. If they would agree and get on board then it would be similar to when Hershey moved to Pennsylvania. Now ALL dairy farmers are his. Just a thought
      KBLB
      Lime Time Lime Time 3 minutes ago
      GCANnon looks like it's pumping up 🧨
      GCAN
      ShawnP123 ShawnP123 3 minutes ago
      Jensen might also discuss the optical link since they're looking at that vs hard circuit connections. Should save some power and increase overall performance within the Rubin and/or next gen products.
      NVDA
      hedge_fun hedge_fun 4 minutes ago
      You are really going out on a limb there.......

      Didn't you hear/read about the worm poop?

      Folks have really tried to help this outfit over the years. Capt. Ed comes to mind, as does Raider.

      It has been pointed out that Tim and Kyle were told by Dr. Parso
      SFRX
      Wooden Indian Wooden Indian 4 minutes ago
      Peter, I'm buying down here.
      Silver has made a bottom and will explode makin your job a whole lot easier.
      TSLVF
      marcis marcis 4 minutes ago
      Yes but people trading of the post 2021 OTC can’t sit still and sell to stack the bid two tics lower

      Of course RDAR is insanely undervalued but 40 million stacked bid sitters think it should be cheaper

      Yup trading has gone to chet
      RDAR
      Wooden Indian Wooden Indian 4 minutes ago
      Peter, I'm buying down here.
      Silver has made a bottom and will explode makin your job a whole lot easier.
      TSLVF
      magnum15098 magnum15098 4 minutes ago
      I believe somebody is getting tired of waiting.
      APRU
      threewheeler threewheeler 5 minutes ago
      FDCT see ya at .20s shortly
      FDCT
      Backstabbed Backstabbed 5 minutes ago
      wallahi let's see $0.05 then $0.10 then $0.20 then $0.50 then $1.00 then $2.00. Go $ZHUD
      ZHUD
      JustJack JustJack 5 minutes ago
      Here is a question asked on the Discord a week ago and has not been, nor will be, answer because it is not a PUMP/POSITIVE question.

      Mr Transparent CEO... what is the answer besides "STF* and stop with the FUD!"

      tigersportchamp
      Last Tuesday at 3:55 PM
      In t
      AITX
      gp22 gp22 5 minutes ago
      $SVRE: EVERY micro & nano-float Israel play ripping...$SVRE, w/ 1.1M Total shares is just starting to go...$SVRE can rip really big here...Heads up.
      SVRE
      benhor benhor 5 minutes ago
       $SVHM GOING UP SUPER FAST 

      0.0528 +0.0107 25.42%

      SVHM
      when in rome when in rome 5 minutes ago
      This down day is a bit of a disappointment after what happened two days ago.
      CEOS
      samson8 samson8 5 minutes ago
      That's 8 billion shares right if they fully diluted? Looks like an authorized share increase would be in order here as well. Another Carnes dilution scheme
      GMZP
      konshe konshe 5 minutes ago
      WOW ASII #1 on BB, huge buyers will come in, Pennies be reached soon.
      ASII
      benhor benhor 5 minutes ago
       $SVHM GOING UP SUPER FAST 

      0.0528 +0.0107 25.42%

      SVHM
      georgie18 georgie18 5 minutes ago
      It ran from .30 to $5 range ...is that not good enough for you...🥳...Its Overbought so it needs to let off some steam...
      KULR
      benhor benhor 6 minutes ago
       $SVHM GOING UP SUPER FAST 

      0.0528 +0.0107 25.42%

      SVHM
      Backstabbed Backstabbed 6 minutes ago
      $BURU - BOOOOOOOOM! NHOD $0.8888 🤑
      BURU
      Lime Time Lime Time 6 minutes ago
      Will pump fast when it goes 🚀
      ECOX
      gp22 gp22 6 minutes ago
      $SVRE: EVERY micro & nano-float Israel play ripping...$SVRE, w/ 1.1M Total shares is just starting to go...$SVRE can rip really big here...Heads up.
      SVRE

      Your Recent History

      NASDAQ
      HJLI
      Hancock Jaffe Laboratories
      BIT
      UC6Y5K
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads